ORBIMED ADVISORS LLC sold 3.57M shares of COMPASS THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.68M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/11/2025ACC: 0000947871-25-000384
Director10% Owner
Since Jun 2020
-3.57M
Net shares
Net seller
$5.68M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.57M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−3.57M
Price / share
$1.59
Trade value
$5.68M
% of position
New position
4/9/2025
3.57M→0.00
Total
Net shares
−3.57M
Net value
-$5.68M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/9/2025 | S · Sale | −3.57M | $1.59 | $5.68M | New position | 3.57M | 0.00 |
| Total | −3.57M | -$5.68M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned15.22M
Total
15.22M indirect15.22M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.22M | Indirect |
| Total | 15.22M | 15.22M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported